| Literature DB >> 32334596 |
Todd J Lucas1,2,3, Carlos Toledo4, Stephanie M Davis4, D Heather Watts5, Joseph S Cavanaugh5, Valerian Kiggundu6, Anne G Thomas7, Elijah Odoyo-June8, Collen Bonnecwe9, Tintswalo Hilda Maringa10, Enilda Martin11, Ambrose Wanyonyi Juma12, Sinokuthemba Xaba13, Shirish Balachandra14, Jotamo Come15, Marcos Canda16, Rose Nyirenda17, Wezi Msungama18, James Odek19, Gissenge J I Lija20, Erick Mlanga21, James Exnobert Zulu22, Heidi O'Bra23, Omega Chituwo24, Mekondjo Aupokolo25, Denis A Mali26, Brigitte Zemburuka27, Kananga Dany Malaba28, Onkemetse Conrad Ntsuape29, Jonas Z Hines4.
Abstract
BACKGROUND: Male circumcision confers partial protection against heterosexual HIV acquisition among men. The President's Emergency Plan for AIDS Relief (PEPFAR) has supported > 18,900,000 voluntary medical male circumcisions (VMMC). Glans injuries (GIs) are rare but devastating adverse events (AEs) that can occur during circumcision. To address this issue, PEPFAR has supported multiple interventions in the areas of surveillance, policy, education, training, supply chain, and AE management.Entities:
Keywords: Amputation; HIV; Intraoperative complications; Male circumcision
Year: 2020 PMID: 32334596 PMCID: PMC7183662 DOI: 10.1186/s12894-020-00613-6
Source DB: PubMed Journal: BMC Urol ISSN: 1471-2490 Impact factor: 2.264
Fig. 1Number of glans injuries reported to PEPFAR by country, 2015–2018, N = 36. During 2015–2018, 12.8 million male circumcisions were performed in PEPFAR-supported VMMC programs, 11.0 million of these had a known age recorded, of which 5.3 million were among patients aged < 15 years. * eSwatini, Ethiopia, Lesotho, Rwanda, and Uganda reported no GIs over this time period
Rate of glans injuries per 100,000 VMMCs performed in patients less than 15 years old
| Year | Any glans injury | Glans injury related to FG | ||||
|---|---|---|---|---|---|---|
| Number of injuries | Number of circumcisions age 0–14 | Number of injuries per 100,000 circumcisions (95% CI)b | Number of injuries | Number of circumcisions age 10–14 | Number of injuries per 100,000 circumcisions (95% CI)c | |
| 2015a | 8 | 1,099,859 | 0.73 (0.31–1.43) | 7 | 1,060,878 | 0.66 (0.26–1.36) |
| 2016 | 7 | 963,067 | 0.73 (0.29–1.50) | 7 | 953,357 | 0.73 (0.30–1.51) |
| 2017 | 11 | 1,572,079 | 0.70 (0.35–1.25) | 8 | 1,560,375 | 0.51 (0.22–1.01) |
| 2018 | 7 | 1,689,178 | 0.41 (0.17–0.85) | 4 | 1,672,993 | 0.24 (0.07–0.61) |
| Overall | 33 | 5,324,183 | 0.62 (0.43–0.87) | 26 | 5,247,603 | 0.50 (0.32–073) |
In July 2014, WHO announced the risk of glans injury with FG method in males 10–14 years. PEPFAR followed shortly thereafter disallowing FG use in this age group. Data on glans injury rate prior to 2015 is not available
3 glans injuries reported retrospectively from 2014 were excluded
The number of PEPFAR notifiable AEs, which include death, glans injuries, tetanus, any AE resulting in permanent deformity or disability, and any AE requiring hospital admission for 3 days or more reported each year increased during this time period. This is suspected to correspond with improved reporting capacity to PEPFAR within countries implementing VMMC. However, although reporting to PEPFAR is mandatory, ascertainment of NAERS is not known
a2015 includes an extra quarter of VMMCs in the denominator, corresponding to Oct-Dec 2014 (i.e., FY2015Q1). This data was not disaggregated at the time. Thus, the actual rate for 2015 is slightly higher than shown, although unknown to what degree
bP-value = 0.02 for testing a trend in rates across years
cP-value < 0.01 for testing a trend in rates across years
FG forceps-guided method; CI confidence interval
Circumstances surrounding glans injuries occurring within PEPFAR-supported VMMC programs, 2015–2018
| Number (%), | |
|---|---|
| Median (25, 75%) | 10 (10, 11) |
| Mean (range) | 10 (< 1–14) |
| Mode ( | 10 |
| 8 am – Noon | 7 (19) |
| Noon – 4 pm | 13 (36) |
| After 4 pm | 8 (22) |
| Unknown | 8 (12) |
| Physician | 8 (22) |
| Clinical Officer/ Clinical Associate | 8 (22) |
| Nurse | 4 (11) |
| Other | 1 (3) |
| Unknown | 15 (42) |
| Adequate | 2 (6) |
| Inadequate | 5 (14) |
| Unknown | 29 (81) |
| Yes | 9 (25) |
| No mention | 21 (58) |
| Record unavailable | 6 (17) |
| Yes, inaccurate documentation | 11 (31) |
| Yes, failure to report as required | 3 (8) |
| No | 16 (44) |
| Unknown | 6 (17) |
| Urologist | 17 (47) |
| Pediatric Surgeon | 8 (22) |
| Other Surgeon | 2 (6) |
| Unknown | 3 (8) |
| Not or unknown if referred | 6 (17) |
1Adequate = AE report indicates adequate training for dorsal slit method, inadequate = report indicates that there was a lack of adequate training, unknown = no mention of training in the report
2Documentation of a concern that a heavy workload may have been a contributing factor to the glans injury
3Documentation of a concern that VMMC provider or clinic attempted to hide or alter evidence concerning the glans injury (for example, documenting DS method when FG method was actually performed)
Glans injury type by male circumcision method in PEPFAR supported VMMC programs, 2015–2018
| MC method | Amputation | Laceration | Strangulation | Unknown type of injury | Total | ||
|---|---|---|---|---|---|---|---|
| Complete | Partial | Degree not specified | |||||
| Forceps-guided | 9 (31%) | 11 (38%) | 1 (3%) | 3 (10%) | 0 (0%) | 5 (17%) | 29 (100%) |
| Dorsal slit | 0 (0%) | 0 (0%) | 0 (0%) | 3 (75%) | 1 (25%) | 0 (0%) | 4 (100%) |
| Mogen clampa | 0 (0%) | 2 (67%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (33%) | 3 (100%) |
| All methods | 9 (25%) | 13 (36%) | 1 (3%) | 6 (17%) | 1 (3%) | 6 (17%) | 36 (100%) |
aMogen clamp used only in early infant (< 60 days old) circumcisions
Fig. 2Glans injuries clinical management, PEPFAR-supported VMMC programs, 2015–2018. *Two outliers excluded: one was an amputation not diagnosed for 2 weeks and one was a strangulation injury not diagnosed for 4 weeks. †Ten cases were known to have been referred but referral time was missing. ‡Eight cases were known to have been repaired but repair time was missing. §Healing well implies reattached tissue was viable for repaired amputations or healing without documented impairment for repaired lacerations. Since long-term follow-up not available in reports, permanent sequelae such as tissue atrophy, scarring, urethral strictures, urethral fistulae, and altered sensation are unknown.